- Home
- SWKS vs NBIX Comparison
SWKS vs NBIX Comparison
Compare SWKS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWKS
- NBIX
- Stock Information
- Founded
- SWKS 1962
- NBIX 1992
- Country
- SWKS United States
- NBIX United States
- Employees
- SWKS N/A
- NBIX N/A
- Industry
- SWKS Semiconductors
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SWKS Technology
- NBIX Health Care
- Exchange
- SWKS Nasdaq
- NBIX Nasdaq
- Market Cap
- SWKS 10.6B
- NBIX 12.0B
- IPO Year
- SWKS 1968
- NBIX 1996
- Fundamental
- Price
- SWKS $68.95
- NBIX $124.56
- Analyst Decision
- SWKS Hold
- NBIX Strong Buy
- Analyst Count
- SWKS 20
- NBIX 20
- Target Price
- SWKS $80.33
- NBIX $163.20
- AVG Volume (30 Days)
- SWKS 4.3M
- NBIX 1.6M
- Earning Date
- SWKS 05-07-2025
- NBIX 07-31-2025
- Dividend Yield
- SWKS 4.06%
- NBIX N/A
- EPS Growth
- SWKS N/A
- NBIX N/A
- EPS
- SWKS 2.56
- NBIX 2.96
- Revenue
- SWKS $3,952,200,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- SWKS N/A
- NBIX $15.99
- Revenue Next Year
- SWKS N/A
- NBIX $14.93
- P/E Ratio
- SWKS $26.93
- NBIX $41.97
- Revenue Growth
- SWKS N/A
- NBIX 21.73
- 52 Week Low
- SWKS $47.93
- NBIX $84.23
- 52 Week High
- SWKS $120.86
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- SWKS 52.03
- NBIX 65.13
- Support Level
- SWKS $67.52
- NBIX $121.42
- Resistance Level
- SWKS $71.76
- NBIX $125.63
- Average True Range (ATR)
- SWKS 1.79
- NBIX 2.85
- MACD
- SWKS -0.58
- NBIX -0.01
- Stochastic Oscillator
- SWKS 25.04
- NBIX 88.89
About SWKS Skyworks Solutions Inc.
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.